BVS vs GIS · rev $285.3M vs P/E 8.2, rev $4.61B
Bioventus Inc (BVS) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
Latest reported GIS revenue for 2026-05-31 was $4.61B. Net income was -$2.01B. Revenue was up 1.2% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
BVS currently screens at market cap $495.1M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the BVS and GIS stock pages for the full models.
Not investment advice.